{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:04:43Z","timestamp":1788174283114,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12016-011-8262-2","type":"journal-article","created":{"date-parts":[[2011,3,14]],"date-time":"2011-03-14T04:42:02Z","timestamp":1300077722000},"page":"131-134","source":"Crossref","is-referenced-by-count":34,"title":["Skin Manifestations Induced by TNF-Alpha Inhibitors in Juvenile Idiopathic Arthritis"],"prefix":"10.1007","volume":"42","author":[{"given":"Irene","family":"Pontikaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucretia Adina","family":"Frasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Gianotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gelmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Gerloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"8262_CR1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/ard.2004.020719","volume":"63","author":"P Mease","year":"2004","unstructured":"Mease P (2004) TNF-\u03b1 therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis 63:755\u2013758","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"8262_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/ard.2004.032276","volume":"64","author":"LS Winterfield","year":"2005","unstructured":"Winterfield LS, Menter A, Gordon K, Gottlieb A (2005) Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis 64(Suppl 2):87\u201390","journal-title":"Ann Rheum Dis"},{"key":"8262_CR3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00002281-200307000-00003","volume":"15","author":"PP Sfikakis","year":"2003","unstructured":"Sfikakis PP, Kollias G (2003) Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 15:380\u2013386","journal-title":"Curr Opin Rheumatol"},{"key":"8262_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86:242\u2013251","journal-title":"Medicine (Baltimore)."},{"key":"8262_CR5","first-page":"380","volume":"34","author":"JD Cohen","year":"2007","unstructured":"Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P (2007) Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol 34:380\u2013385","journal-title":"J Rheumatol"},{"key":"8262_CR6","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","volume":"52","author":"PP Sfikakis","year":"2005","unstructured":"Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A (2005) Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 52:2513\u20132518","journal-title":"Arthritis Rheum"},{"key":"8262_CR7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","volume":"73","author":"B Saint Marcoux","year":"2006","unstructured":"Saint Marcoux B, De Bandt M, CRI (Club Rhumatismes et Inflammation) (2006) Vasculitides indiced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73:710\u2013713","journal-title":"Joint Bone Spine"},{"key":"8262_CR8","first-page":"434","volume":"34","author":"CH Roux","year":"2007","unstructured":"Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euller-Ziegler L (2007) New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect\u03b1. J Rheumatol 34:434\u2013437","journal-title":"J Rheumatol"},{"key":"8262_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/ard.2005.037424","volume":"65","author":"S Kary","year":"2006","unstructured":"Kary S, Worm M, Audring H, Huscher D, Renelt M, S\u00f6rensen H, St\u00e4nder E, Maass U, Lee H, Sterry W, Burmester GR (2006) New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis 65:405\u2013407","journal-title":"Ann Rheum Dis"},{"key":"8262_CR10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/ard.2007.082842","volume":"67","author":"JD Carter","year":"2008","unstructured":"Carter JD, Gerard HC, Hudson AP (2008) Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum. Ann Rheum Dis 67:1181\u20131183","journal-title":"Ann Rheum Dis"},{"key":"8262_CR11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1346-8138.2007.00312.x","volume":"34","author":"H Takahashi","year":"2007","unstructured":"Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Ashida T, Kohgo Y, Iizuka H (2007) Psoriasiform and pustular eruption induced by infliximab. J Dermatol 34:468\u2013472","journal-title":"J Dermatol"},{"key":"8262_CR12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.23835","volume":"59","author":"AN Collamer","year":"2008","unstructured":"Collamer AN, Guerrero KT, Henning JS, Battafarano DF (2008) Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 59:996\u20131001","journal-title":"Arthritis Rheum"},{"key":"8262_CR13","first-page":"478","volume":"61","author":"B Kolarz","year":"2007","unstructured":"Kolarz B, Targo\u03b1ska-Stepniak B, Darmochwa\u03b1-Kolarz D, Majdan M (2007) Autoimmune aspects of treatment with TNF-alpha inhibitors. Postepy Hig Med Dosw (Online) 61:478\u2013484, Review. Polish","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"8262_CR14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","volume":"54","author":"T Markham","year":"2006","unstructured":"Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ (2006) Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol 54:1003\u20131012","journal-title":"J Am Acad Dermatol"},{"key":"8262_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10067-007-0789-5","volume":"27","author":"S Aslanidis","year":"2008","unstructured":"Aslanidis S, Pyrpasopoulou A, Douma S, Triantafyllou A (2008) Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine. Clin Rheumatol 27:377\u2013380","journal-title":"Clin Rheumatol"},{"key":"8262_CR16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","volume":"143","author":"GC Gannes De","year":"2007","unstructured":"De Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP (2007) Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 143:223\u2013231","journal-title":"Arch Dermatol"},{"key":"8262_CR17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1468-3083.2008.02935.x","volume":"22","author":"AC Davaine","year":"2008","unstructured":"Davaine AC, Saraux A, Prigent S, Kupfer-Bessaguet I, Roswag D, Plantin P, Schoenlaub P, Talarmin F, Zagnoli A, Misery L (2008) Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study. J Eur Acad Dermatol Venereol 22:1471\u20131477","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8262_CR18","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.20155","volume":"50","author":"W Beuthien","year":"2004","unstructured":"Beuthien W, Mellinghoff HU, von Kempis J (2004) Skin reaction to adalimumab. Arthritis Rheum 50:1690\u20131692","journal-title":"Arthritis Rheum"},{"key":"8262_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archderm.143.2.233","volume":"143","author":"DF Fiorentino","year":"2007","unstructured":"Fiorentino DF (2007) The Yin and Yang of TNF-{alpha}inhibition. Arch Dermatol 143:233\u2013236","journal-title":"Arch Dermatol"},{"key":"8262_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3949\/ccjm.73.3.251","volume":"73","author":"L Calabrese","year":"2006","unstructured":"Calabrese L (2006) The yin and yang of tumor necrosis factor inhibitors. Cleve Clin J Med 73:251\u2013256","journal-title":"Cleve Clin J Med"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-011-8262-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8262-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T06:27:36Z","timestamp":1741069656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-011-8262-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["8262"],"URL":"https:\/\/doi.org\/10.1007\/s12016-011-8262-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}